Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program
      Biotech

      Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

      July 26, 2025
      UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology
      Biotech

      UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

      July 26, 2025
      B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight
      Biotech

      B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

      July 25, 2025
      Leads Biolabs Lists on HKEX, Raising USD 189 Million Through Initial Public Offering
      Biotech

      Leads Biolabs Lists on HKEX, Raising USD 189 Million Through Initial Public Offering

      July 25, 2025
      Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint
      Biotech

      Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint

      July 25, 2025
      Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight
      Biotech

      Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

      July 24, 2025
      iOnctura Strengthens Medical and Commercialization Expertise with Two Non-Executive Board Appointments
      Biotech

      iOnctura Strengthens Medical and Commercialization Expertise with Two Non-Executive Board Appointments

      July 24, 2025
      Global Dental Leaders to Convene in Shanghai  for FDI World Dental Congress 2025
      Biotech

      Global Dental Leaders to Convene in Shanghai for FDI World Dental Congress 2025

      July 23, 2025
      Dash Bio Secures $11M to Accelerate a New Era in Bioanalysis — Bringing Total Funding to $17.5M
      Biotech

      Dash Bio Secures $11M to Accelerate a New Era in Bioanalysis — Bringing Total Funding to $17.5M

      July 23, 2025
      SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study
      Biotech

      SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

      July 22, 2025
      « 1 … 10 11 12 13 14 … 133 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026